Endo Pharmaceuticals Holdings Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Endo Pharmaceuticals Holdings Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Endo Pharmaceuticals Holdings Inc. in the form of a SWOT analysis
An in-depth view of the business model of Endo Pharmaceuticals Holdings Inc. including a breakdown and examination of key business segments
Intelligence on Endo Pharmaceuticals Holdings Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Endo Pharmaceuticals Holdings Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Endo Pharmaceuticals Holdings (Endo) is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and central precocious puberty. The company primarily operates in the US. Endo is headquartered in Chadds Ford, Pennsylvania and employed 1,487 people as of February 19, 2010. The company recorded revenues of $1,460.8 million during the financial year (FY) ended December 2009, an increase of 15.9% over FY2008. The operating profit of the company was $390 million during FY2009, an increase of 0.7% over FY2008. The net profit was $266.3 million in FY2009, an increase of 4.3% over FY2008.
Reasons to Purchase:
Gain understanding of Endo Pharmaceuticals Holdings Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Endo Pharmaceuticals Holdings Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Endo Pharmaceuticals Holdings Inc.’s business structure, strategy and prospects